SKI Market

Indian Indices

Nifty

24,500.90 -211.15
(-0.85%)

Sensex

80,015.48 -65.09
( -0.08%)

Bank Nifty

53,820.35 -630.10
( -1.16%)

Nifty IT

35,488.80 -574.40
( -1.59%)

Global Indices

Nasdaq

45,661.67 75.43
(0.17%)

Dow Jones

6,523.31 20.91
(0.32%)

Hang Seng

42,793.22 272.95
(0.64%)

Nikkei 225

9,216.82 -38.68
(-0.42%)

Forex

USD-INR

87.60 -0.05
(-0.06%)

EUR-INR

102.16 0.14
(0.13%)

GBP-INR

118.33 0.25
(0.21%)

JPY-INR

0.60 0.00
(0.24%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vesuvius India Ltd

Industry : Refractories / Intermediates

BSE Code

ISIN Demat

Book Value()

520113

INE386A01023

75.0108435

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VESUVIUS

40.15

10064.83

EPS(TTM)

Face Value()

Div & Yield %

12.35

0.29

Back

balaxi pharmaceuticals ltd

IRIS Business Services consolidated net profit declines 93.62% in the June 2025 quarter

Aug 13,2025

Net profit of IRIS Business Services declined 93.62% to Rs 0.18 crore in the quarter ended June 2025 as against Rs 2.82 crore during the previous quarter ended June 2024. Sales rose 7.99% to Rs 29.86 crore in the quarter ended June 2025 as against Rs 27.65 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	29.86	27.65	8
OPM %	0.03	13.56	-
PBDT	1.05	4.10	-74
PBT	0.32	3.62	-91
NP	0.18	2.82	-94

24,500.90 -211.15 (-0.85%)

80,015.48 -65.09 ( -0.08%)

53,820.35 -630.10 ( -1.16%)

35,488.80 -574.40 ( -1.59%)

45,661.67 75.43 (0.17%)

6,523.31 20.91 (0.32%)

42,793.22 272.95 (0.64%)

9,216.82 -38.68 (-0.42%)

87.60 -0.05 (-0.06%)

102.16 0.14 (0.13%)

118.33 0.25 (0.21%)

0.60 0.00 (0.24%)